下载
Anti-Human VEGF & Angiopoietin-2 Bispecific Reference Antibody (Vanucizumab, RUO)
Overview
Catalog No. HT073026
Brand abinScience
Tested applications FCM
Species reactivity Human
Form Liquid
Storage buffer 0.01M PBS pH 7.4
Purity >95% purity as determined by SDS-PAGE.
Isotype human IgG1 - kappa - lambda with half-IG VL-CH1/VH-CK crossover
Applications ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Target Vascular endothelial growth factor A, VPF, VEGFA, VEGF, Vascular permeability factor, VEGF-A, ANG-2, ANGPT2, Angiopoietin-2
Purification Protein A/G purified from cell culture supernatant.
Endotoxin level < 10 EU/mg
Expression system Mammalian cells
Accession P15692 & O15123
Stability and Storage Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative nameBispecific, RG-7221, RG7221, RO5520985, 1448221-05-3
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype Control Human IgG1 Recombinant Isotype Control Antibody (HyHEL-10) (HV080407)
Human IgG1 Recombinant Isotype Control Antibody (13R4) (HV080507)
Images


Bioactivity
Detects Human VEGFA in indirect ELISAs.

SEC-HPLC
SEC-HPLC detection for Research Grade Vanucizumab.

Bioactivity
Detects Human ANGPT2 in indirect ELISAs.

Flow CytoMetry
Flow-cytometry using FITC anti-human VEGFA&ANGPT2 antibody. U87 cells were fixed and permeabilized, then stained with an irrelevant antibody (Blue Histogram) or an FITC anti-human VEGFA&ANGPT2 monoclonal antibody (Catalog: HT073026, Yellow Histogram) at a concentration of 5 µg/ml for 30 mins at RT. After washing, cells analysed on a NovoCyte Flow Cytometer.